Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

QurAlis

QurAlis
2016 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Seed LATEST DEAL TYPE
$5.5M LATEST DEAL AMOUNT
6 INVESTORS
Description

Operator of a biotechnology agency intended to discover and develop potential new therapeutics for ALS. The company's agency focuses on developing precision therapeutics for ALS and other neurological diseases, enabling patients to avail effective cure from three different forms of ALS.clearance system in cells, enabling doctors to successfully cure ALS.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Therapeutic Devices
Primary Office
  • 700 Main Street, North
  • Cambridge, MA 02139
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore QurAlis’s full profile, request a free trial.

QurAlis Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 19-Nov-2018 $5.5M 00.00 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

QurAlis Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Amgen Ventures Corporate Venture Capital Minority 000 0000 000000 0
BioInnovation Capital Venture Capital Minority 000 0000 000000 0
MP Healthcare Venture Management Venture Capital Minority 000 0000 000000 0
Viva biotech VC-Backed Company Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

QurAlis Executive Team (5)

Name Title Board
Seat
Contact
Info
Kasper Roet Ph.D Co-Founder, Board Member, President & Chief Executive Officer
Daniel Elbaum Ph.D Chief Scientific Officer
Kevin Eggan Ph.D Co-Founder
Jonathan Fleming Co-Founder & Executive Chairman
Clifford Woolf Ph.D Co-Founder

QurAlis Board Members (4)

Name Representing Role Since Contact
Info
David Margulies MD Self Board Member 000 0000
Jeffrey Moore Ph.D MP Healthcare Venture Management Board Member 000 0000
Johannes Fruehauf Ph.D BioInnovation Capital Board Member 000 0000
Jonathan Fleming Self Co-Founder & Executive Chairman 000 0000